Phrixus Pharmaceuticals
Phrixus Pharmaceuticals, Inc. develops and commercializes pharmaceuticval s and therapies related to heart failure. The company develops Carmeseal, a therapy for the treatment of heart failure. Phrixus Pharmaceuticals, Inc. was incorporated in 2006 and is based in Ann Arbor, Michigan.
Industries
biotechnology
health-care
pharmaceutical
Nr. of Employees
small (1-50)
Phrixus Pharmaceuticals
Ann Arbor, Michigan, United States, North America
Patents
Compositions and methods for treating and preventing skeletal muscle deficiencies
US-9107940-B2
View DetailsCompositions and methods for treating and preventing skeletal muscle deficiencies
US-8852568-B2
View Details
Compositions and methods for treating and preventing skeletal muscle deficiencies
US-9107940-B2
View DetailsCompositions and methods for treating and preventing skeletal muscle deficiencies
US-8852568-B2
View DetailsExpertise Areas
- Pharmaceutical development
- Clinical development and operations
- Regulatory compliance and submissions
- GMP manufacturing and CMC
Key Technologies
- Preclinical models
- Clinical trial management platforms
- Analytical chemistry and assay development
- GMP manufacturing processes